多模态影像在瓣膜性心脏病日常实践中的应用
综述总结了多模态影像在瓣膜性心脏病评估中的当前证据,指出超声心动图仍是主要影像技术,但全面评估需结合多模态影像分析瓣膜功能障碍机制、准确量化严重程度并排除瓣外后果。手术和经导管治疗的进展推动了对精细多模态影像的需求,以辅助患者和手术选择,多模态影像的整合有望实现个体化管理策略。
要点
- 超声心动图仍是瓣膜性心脏病的主要影像技术,但需多模态影像全面评估。
- 多模态影像用于分析瓣膜功能障碍机制、量化严重程度及排除瓣外后果。
- 手术和经导管治疗进展要求精细多模态影像辅助患者和手术选择。
核心结论
- 多模态影像的整合有望真正实现瓣膜性心脏病患者的个体化管理策略。
研究设计与样本
- 综述,总结多模态影像在瓣膜性心脏病中应用的当前证据。
主要发现
- 超声心动图仍是主要影像技术,但当代评估需全面分析瓣膜功能障碍机制、准确量化严重程度并积极排除瓣外后果。
- 手术和经导管治疗的进展驱动了对精细多模态影像的需求,以辅助患者和手术选择。
- 多模态影像技术快速发展,许多技术已可用于常规临床实践。
临床怎么用
- 在瓣膜性心脏病患者评估中,应结合多模态影像分析瓣膜功能障碍机制、量化严重程度并排除瓣外后果。
- 利用多模态影像辅助手术和经导管治疗的患者选择与手术规划。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Our understanding of the complexities of valvular heart disease (VHD) has evolved in recent years, primarily because of the increased use of multimodality imaging (MMI). Whilst echocardiography remains the primary imaging technique, the contemporary evaluation of patients with VHD requires comprehensive analysis of the mechanism of valvular dysfunction, accurate quantification of severity, and active exclusion extravalvular consequences. Furthermore, advances in surgical and percutaneous therapies have driven the need for meticulous multimodality imaging to aid in patient and procedural selection. Fundamental decision-making regarding whom, when, and how to treat patients with VHD has become more complex. There has been rapid technological advancement in MMI; many techniques are now available in routine clinical practice, and their integration into has the potential to truly individualize management strategies. This review provides an overview of the current evidence for the use of MMI in VHD, and how various techniques within each modality can be used practically to answer clinical conundrums.
引用
- Reid A, Blanke P, Bax JJ, et al. Multimodality imaging in valvular heart disease: how to use state-of-the-art technology in daily practice. Eur Heart J. 2021. PMID: 33186469. doi:10.1093/eurheartj/ehaa768
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。